Drugs & Therapy Perspectives

, Volume 5, Issue 3, pp 11–12 | Cite as

Life-long drug therapy required for Wilson’s disease

New Drugs and Therapeutics


Penicillamine Wilson Disease Copper Accumulation Trientine Iron Zinc 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hefter H. Wilson’s Disease: review of pathophysiology, clinical features and drug treatment. CNS Drugs 1994; 2: 26–39CrossRefGoogle Scholar
  2. 2.
    Houwen RHJ, van Hattum J, Hoogenraad TU. Wilson disease. Neth J Med 1993; 43: 26–37PubMedGoogle Scholar
  3. 3.
    Scheinberg H. Wilson’s Disease. In: Wilson JD, et al, (Eds.) Harrison’s principles of internal medicine, 12th ed. New York, McGraw-Hill, 1991; pp. 1843–5Google Scholar
  4. 4.
    Stremmel W, Meyerrose K-W, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720–6PubMedGoogle Scholar
  5. 5.
    Physicians GenRx. Data Pharmaceutica Inc. New York 1994; pp. 1726–9 & 2185–7Google Scholar
  6. 6.
    American Hospital Formulary Service Drug Information. American Society of Hospital Pharmacists, Bethesda, 1994; pp. 1974–7Google Scholar
  7. 7.
    British National Formulary. 1993; 27: 361Google Scholar
  8. 8.
    Walshe JM, Yealland M. Chelation treatment of Wilson’s disease. Q J Med 1993; 86: 197–204PubMedGoogle Scholar

Copyright information

© Adis International Limited 1995

Personalised recommendations